Do you know the feeling of product loss?

Article

For More Information

RoSS® // Robust Storage and Shipping for all single use bags

Liquid bulk drug substance is of utmost value after manufacturing from Biopharma industries. The single-use bag independent platform RoSS® helps to avoid product loss through breakages through robust composition and makes it possible to introduce your flexible end-to-end solution in drug substance logistics.
Watch Video


Case study: Product Loss Cost efficiency

Biopharmaceutical companies have largely accepted a certain level of product loss when managing drug substances in single-use systems - unaware that solutions exist to streamline process steps and dramatically diminish product loss. A global biotechnology company’s goal was to reduce the current product loss below 0.5%
Download


Case study: Product Loss Bag independence

The choice of single-use bioprocess containers in biopharmaceutical handling has had consequences for the performance and requirements in biomanufacturing until now. Lack of compatibility and inflexibility of platform systems have determined future investments. A global CDMO has set its goal to find single-use bag-independent solutions to increase process flexibility whilst minimizing product loss rate.
Download

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
Mike Schaefers Simtra BioPharma Solutions, Shiva Khalafpour MilliporeSigma, the Life Science Business of Merck KGaA, Darmstadt, Germany
Chris Hagan, SCIEX
Daniel Fischer, Tevard
Junevity Co-founder & CEO, John Hoekman, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.